Opko, Bristol-Myers Collaboration to Include Alzheimer's Biomarkers
January 14, 2013
Opko, Bristol-Myers Collaboration to Include Alzheimer's Biomarkers
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Emerald Logic, King's College London Collaborate on Identifying Alzheimer's Markers
February 5, 2013 / GenomeWeb Daily News - Opko Inks Deal with BMS to ID Response Markers for Orencia; Again Retools Peptoid-Based Dx Platform
January 18, 2013 / ProteoMonitor - Opko Health Revamping Peptoid-Based Diagnostic Platform, Prepping Alzheimer's Test for Market
July 27, 2012 / ProteoMonitor - Opko Partners with Bristol-Myers Squibb on Alzheimer's Blood Test
January 10, 2011 / GenomeWeb Daily News - DiaGenic, Pfizer Sign Deal for Alzheimer's Biomarker Discovery
December 17, 2010 / GenomeWeb Daily News